WWM
HAE icon

Wolff Wiese Magana’s Haemonetics HAE Stock Holding History

Wolff Wiese Magana’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-20
Closed -$1.49K – 995
2025
Q2 		$1.49K Hold
20
– – ﹤0.01% 775
2025
Q1 		$1.27K Hold
20
– – ﹤0.01% 812
2024
Q4 		$1.56K Hold
20
– – ﹤0.01% 740
2024
Q3 		$1.61K Buy
+20
New +$1.62K ﹤0.01% 773

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.82B AUM 7.52% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolff Wiese Magana's HAE Position: Q3 2025 in Review

Wolff Wiese Magana sold out of Haemonetics (HAE) in Q3 2025, closing a stake of 20 shares — an estimated $1.49K sold.

Wolff Wiese Magana first reported a position in HAE in Q3 2024 and held it in 4 quarters. The position peaked at $1.61K in Q3 2024. 301 funds tracked by Wall St. Rank hold HAE as of Q3 2025.

  • Wolff Wiese Magana reported no remaining Haemonetics position as of Q3 2025 after selling out during the quarter.
  • Wolff Wiese Magana sold 20 Haemonetics shares in Q3 2025, an estimated $1.49K.
  • Wolff Wiese Magana first reported a position in Haemonetics in Q3 2024 and held it in 4 quarters.
  • Wolff Wiese Magana's Haemonetics position peaked at $1.61K in Q3 2024.
  • 301 funds tracked by Wall St. Rank held Haemonetics as of Q3 2025.

Based on Wolff Wiese Magana's 13F filing for Q3 2025, filed 28 Oct 2025.